BASAGLAR
Drug
Lilly USA, LLC
Total Payments
$2.0M
Transactions
61,340
Doctors
21,257
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,227 | 71 | 36 |
| 2023 | $4,407 | 269 | 187 |
| 2022 | $5,336 | 344 | 291 |
| 2021 | $26,156 | 1,336 | 1,042 |
| 2020 | $249,421 | 17,393 | 8,946 |
| 2019 | $244,654 | 20,547 | 10,326 |
| 2018 | $145,092 | 6,113 | 2,824 |
| 2017 | $1.3M | 15,267 | 5,726 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $873,635 | 825 | 43.9% |
| Food and Beverage | $782,885 | 59,996 | 39.3% |
| Consulting Fee | $302,943 | 90 | 15.2% |
| Travel and Lodging | $31,776 | 429 | 1.6% |
Top Doctors Receiving Payments for BASAGLAR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Endocrinology, Diabetes & Metabolism | Plano, TX | $53,248 | 48 |
| , M.D | Endocrinology, Diabetes & Metabolism | Nashville, TN | $51,225 | 49 |
| , MD | Internal Medicine | New York, NY | $50,499 | 59 |
| , M.D | Endocrinology, Diabetes & Metabolism | Melbourne, FL | $46,355 | 72 |
| , M.D | Specialist | Phoenix, AZ | $45,855 | 68 |
| , M.D | Specialist | Arlington, TX | $35,233 | 46 |
| , MD | Endocrinology, Diabetes & Metabolism | Flemington, NJ | $30,472 | 43 |
| , MD | Endocrinology, Diabetes & Metabolism | Little Rock, AR | $28,639 | 69 |
| , MD | Internal Medicine | Philadelphia, PA | $27,452 | 47 |
| , M.D | Endocrinology, Diabetes & Metabolism | Opelika, AL | $25,136 | 23 |
| , MD | Internal Medicine | Hopewell, VA | $25,098 | 62 |
| , M.D | Endocrinology, Diabetes & Metabolism | Asheville, NC | $24,855 | 39 |
| , M.D | Endocrinology, Diabetes & Metabolism | Festus, MO | $22,713 | 41 |
| , DO | Endocrinology, Diabetes & Metabolism | Dover, NH | $22,692 | 25 |
| , D.O | Obesity Medicine | Sisters, OR | $22,527 | 50 |
| , M.D | Internal Medicine | Columbia, MD | $22,068 | 23 |
| , MD | Endocrinology, Diabetes & Metabolism | Roanoke, VA | $21,794 | 33 |
| , D.O | Hospitalist | Rochester, NY | $21,754 | 40 |
| , M.D., M.P.H | Family Medicine | New Braunfels, TX | $21,634 | 34 |
| , M.D | Internal Medicine | N New Hyde Pk, NY | $21,256 | 27 |
| , M.D | Endocrinology, Diabetes & Metabolism | Irving, TX | $20,289 | 34 |
| , M.D | Specialist | Escondido, CA | $19,770 | 16 |
| , MD | Endocrinology, Diabetes & Metabolism | Farmington Hills, MI | $19,266 | 19 |
| , MD, FACE, ECNU | Endocrinology, Diabetes & Metabolism | Santa Rosa, CA | $19,030 | 34 |
| , M.D | Endocrinology, Diabetes & Metabolism | Mentor, OH | $18,938 | 37 |
Ad
Manufacturing Companies
- Lilly USA, LLC $2.0M
- Eli Lilly and Company $14,214
- Eli Lilly Export S.A. Puerto Rico Branch $8,543
Product Information
- Type Drug
- Total Payments $2.0M
- Total Doctors 21,257
- Transactions 61,340
About BASAGLAR
BASAGLAR is a drug associated with $2.0M in payments to 21,257 healthcare providers, recorded across 61,340 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2017 to 2024. In 2024, $1,227 was paid across 71 transactions to 36 doctors.
The most common payment nature for BASAGLAR is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($873,635, 43.9% of total).